Literature DB >> 3144248

[Electrophysiological study of pro-arrhythmogenic effects of erythromycin].

J Ponsonnaille1, B Citron, A Richard, J F Trolese, A Chaperon, B Barret, H Gras.   

Abstract

Three cases of torsades de pointe induced by erythromycin have recently been reported. After observing a new case, the authors tried to demonstrate the possible mechanism of the arrhythmogenic action of this molecule. Twenty-two patients undergoing electrophysiological studies in the catheter laboratory to determine the cause of syncope were given an intravenous injection of 10 mg/Kg of erythromycin lactobionate. The drug was injected in 1 minute (bolus) in 11 patients (Group A). The other 11 patients (Group B) received the drug by slow intravenous infusion (20 minutes). Electrophysiological parameters were measured before and after erythromycin. A significant prolongation of the atrial refractory periods (+39 ms), ventricular refractory periods (+20 ms), QT (+20 ms) and QTC intervals (+42 ms) was observed in Group A. These electrophysiological effects could explain an arrhythmogenic action similar to that of antiarrhythmic drugs in Group I of Vaughan-Williams' classification. The slow intravenous infusion of erythromycin in Group B considerably reduced these undesirable secondary effects. This difference was directly related to serum concentrations of the molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144248

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  4 in total

1.  Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).

Authors:  R A Schoenenberger; W E Haefeli; P Weiss; R F Ritz
Journal:  BMJ       Date:  1990-05-26

Review 2.  Possible risk for cardiac arrhythmia related to intravenous erythromycin.

Authors:  W E Haefeli; R A Schoenenberger; P Weiss; R Ritz
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 3.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 4.  Macrolide antibiotics and the risk of cardiac arrhythmias.

Authors:  Richard K Albert; Joseph L Schuller
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.